BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37580792)

  • 1. Societal costs and health related quality of life in adult atopic dermatitis.
    Beretzky Z; Koszorú K; Rencz F; Hajdu K; Borza J; Bodai K; Feifei X; Szegedi A; Sárdy M; Brodszky V
    BMC Health Serv Res; 2023 Aug; 23(1):859. PubMed ID: 37580792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease burden of patients with pemphigus from a societal perspective.
    Brodszky V; Tamási B; Hajdu K; Péntek M; Szegedi A; Sárdy M; Bata-Csörgő Z; Kinyó Á; Gulácsi L; Rencz F
    Expert Rev Pharmacoecon Outcomes Res; 2021 Feb; 21(1):77-86. PubMed ID: 31978314
    [No Abstract]   [Full Text] [Related]  

  • 3. The humanistic and economic burden of atopic dermatitis among adults and adolescents in Saudi Arabia.
    Elezbawy B; Fasseeh AN; Fouly E; Esba LCA; Al Abdulkarim H; Al-Haddab M; Al-Sheikh A; Altawil E; Al Turaiki A; Eshmawi M; Hamadah I; Tannira M; Dalle H; Aderian S; Roshdy A; Jaheen A; Hamad T; Abaza S; Kaló Z
    J Med Econ; 2022; 25(1):1231-1239. PubMed ID: 36426726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humanistic and Economic Impact of Moderate to Severe Plaque Psoriasis in Brazil.
    Lopes N; Dias LLS; Azulay-Abulafia L; Oyafuso LKM; Suarez MV; Fabricio L; Kobata CM; Cestari T; Gontijo B; Sabbag CY; Antonio JR; Romiti R; Pertel PC
    Adv Ther; 2019 Oct; 36(10):2849-2865. PubMed ID: 31432463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-of-illness of atopic dermatitis in Germany: data from dermatology routine care.
    Mohr N; Naatz M; Zeervi L; Langenbruch A; Bieber T; Werfel T; Wollenberg A; Augustin M
    J Eur Acad Dermatol Venereol; 2021 Jun; 35(6):1346-1356. PubMed ID: 33651457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost and quality of life in patients with severe chronic hand eczema refractory to standard therapy with topical potent corticosteroids.
    Cortesi PA; Scalone L; Belisari A; Bonamonte D; Cannavò SP; Cristaudo A; De Pità O; Gallo R; Giannetti A; Gola M; Pigatto PD; Mantovani LG
    Contact Dermatitis; 2014 Mar; 70(3):158-68. PubMed ID: 24102212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Decreased professional performance and quality of life in patients with moderate-to-severe atopic eczema : Results from the German atopic eczema registry TREATgermany].
    Haufe E; Abraham S; Heratizadeh A; Harder I; Zink A; Weisshaar E; Kleinheinz A; von Kiedrowski R; Worm M; Bell M; Wollenberg A; Neubert K; Staubach-Renz P; Hilgers M; Bieber T; Fell I; Homey B; Effendy I; Mempel M; Schäkel K; Beissert S; Weidinger S; Werfel T; Schmitt J
    Hautarzt; 2018 Oct; 69(10):815-824. PubMed ID: 30191254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The burden of atopic dermatitis in adults in Italy.
    Sciattella P; Pellacani G; Pigatto PD; Patrizi A; Peris K; Calzavara-Pinton P; Girolomoni G; Lanati EP; D'ausilio A; Mennini FS
    G Ital Dermatol Venereol; 2020 Feb; 155(1):19-23. PubMed ID: 31525844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Health related quality of life and disease burden of patients with schizophrenia in Hungary].
    Péntek M; Harangozó J; Egerházi A; Kelemen O; Gulácsi L; Baji P; Máttyássy A; Erdélyi R; Lehoczky S; Orlewska E; Vártokné Hevér N; Ferencz A; Brodszky V
    Psychiatr Hung; 2012; 27(1):4-17. PubMed ID: 22493145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Influence of Atopic Dermatitis on Health-Related Quality of Life in Bangladesh.
    Nagata A; Kazi T; Akter Z; Nody FA; Khan MS; Shahriar ASM; Islam MS; Nakagawa T; Inui S
    Int J Environ Res Public Health; 2021 Nov; 18(21):. PubMed ID: 34770105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multinational assessment of work-related productivity loss and indirect costs from a survey of patients with psoriasis.
    Villacorta R; Teeple A; Lee S; Fakharzadeh S; Lucas J; McElligott S
    Br J Dermatol; 2020 Sep; 183(3):548-558. PubMed ID: 31840228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resource utilization, work productivity and costs in patients with hidradenitis suppurativa: a cost-of-illness study.
    Gáspár K; Hunor Gergely L; Jenei B; Wikonkál N; Kinyó Á; Szegedi A; Remenyik É; Kiss N; Jin X; Sárdy M; Beretzky Z; Péntek M; Gulácsi L; Bánvölgyi A; Brodszky V; Rencz F
    Expert Rev Pharmacoecon Outcomes Res; 2022 Apr; 22(3):399-408. PubMed ID: 33629618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Survey of adults living with epilepsy in Hungary: health-related quality of life and costs].
    Péntek M; Bereczki D; Gulácsi L; Mikudina B; Arányi Z; Juhos V; Baji P; Brodszky V
    Ideggyogy Sz; 2013 Jul; 66(7-8):251-61. PubMed ID: 23971356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life and costs in Parkinson's disease: a cross sectional study in Hungary.
    Tamás G; Gulácsi L; Bereczki D; Baji P; Takáts A; Brodszky V; Péntek M
    PLoS One; 2014; 9(9):e107704. PubMed ID: 25229404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Social/economic costs and quality of life in patients with haemophilia in Europe.
    Cavazza M; Kodra Y; Armeni P; De Santis M; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Gulácsi L; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1():53-65. PubMed ID: 27048374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe.
    Cavazza M; Kodra Y; Armeni P; De Santis M; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Péntek M; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1():19-29. PubMed ID: 27038625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic Burden of Adult Patients with Moderate to Severe Atopic Dermatitis Indicated for Systemic Treatment.
    Ariëns LFM; van Nimwegen KJM; Shams M; de Bruin DT; van der Schaft J; van Os-Medendorp H; De Bruin-Weller M
    Acta Derm Venereol; 2019 Jul; 99(9):762-768. PubMed ID: 31073619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social and economic costs and health-related quality of life in non-institutionalised patients with cystic fibrosis in the United Kingdom.
    Angelis A; Kanavos P; López-Bastida J; Linertová R; Nicod E; Serrano-Aguilar P;
    BMC Health Serv Res; 2015 Sep; 15():428. PubMed ID: 26416027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The comparative economic burden of mild, moderate, and severe fibromyalgia: results from a retrospective chart review and cross-sectional survey of working-age U.S. adults.
    Chandran A; Schaefer C; Ryan K; Baik R; McNett M; Zlateva G
    J Manag Care Pharm; 2012; 18(6):415-26. PubMed ID: 22839682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost of illness study for adult atopic dermatitis in Japan: A cross-sectional Web-based survey.
    Murota H; Inoue S; Yoshida K; Ishimoto A
    J Dermatol; 2020 Jul; 47(7):689-698. PubMed ID: 32383191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.